TY - JOUR
T1 - Medical therapy of inflammatory bowel disease
AU - Hanauer, S. B.
AU - Baert, F.
PY - 1994
Y1 - 1994
N2 - Despite advances in pharmacologic approaches, the treatment of ulcerative colitis and Crohn's disease remains a challenge. Prior standards of therapy, sulfasalazine and corticosteroids, are gradually being replaced by mesalamine and alternative immune modulating agents. This article discusses the important pharmacologic properties, mechanisms of action, indications, and complications necessary to apply the expanding armamentarium in clinical practice.
AB - Despite advances in pharmacologic approaches, the treatment of ulcerative colitis and Crohn's disease remains a challenge. Prior standards of therapy, sulfasalazine and corticosteroids, are gradually being replaced by mesalamine and alternative immune modulating agents. This article discusses the important pharmacologic properties, mechanisms of action, indications, and complications necessary to apply the expanding armamentarium in clinical practice.
UR - http://www.scopus.com/inward/record.url?scp=0027996830&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0027996830&partnerID=8YFLogxK
U2 - 10.1016/S0025-7125(16)30108-0
DO - 10.1016/S0025-7125(16)30108-0
M3 - Article
C2 - 7967917
AN - SCOPUS:0027996830
SN - 0025-7125
VL - 78
SP - 1413
EP - 1426
JO - Medical Clinics of North America
JF - Medical Clinics of North America
IS - 6
ER -